Archive: Company News
Company News: Heraeus Medical – New PALAMIX® vacuum mixing system for bone cement optimises organisation of orthopaedic surgery
— The innovative design of PALAMIX® allows a high degree of safety and convenience for both personnel and patients
More efficient organisation of hip and knee joint surgery for the medical staff and patients – these are just a few of the advantages of the new PALAMIX® vacuum mixing system from Heraeus Medical. The new generation makes mixing and application of bone cement even easier and more convenient for permanent anchorage of hip and knee joint prostheses.
Company News: Curetis’ Unyvero Intra-Abdominal Infection (IAI) Cartridge Receives CE Marking
– Product to launch in EMEA at ECCMID Conference
April 22-25, 2017
– IAI Panel covers up to 130 diagnostic targets
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced the successful completion of clinical performance evaluation and CE-IVD marking of its fourth Unyvero Application Cartridge for the diagnosis of severe intra-abdominal infections (IAI).
Curetis Reports Full-Year 2016 Financial Results and Updates 2017 Guidance
– Company strengthens commercial footprint in EMEA; expands installed base by 47%
– Acquisition of GEAR database and Gyronimo platform increase scale and scope of Unyvero offering
– Preparation for Unyvero market launch in the U.S.
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced financial results for the twelve months ended December 31, 2016, and provided further details on its outlook for 2017.
Company News: Curetis Expands Supervisory and Medical Advisory Boards
– Dr. Nils Clausnitzer nominated for election to Supervisory Board; Dr. Melissa Miller appointed to Medical Advisory Board
Curetis N.V. (the “Company” and, together with Curetis GmbH, “Curetis“), a developer of next-level molecular diagnostic solutions, today announced that it has nominated Dr. med. Nils Clausnitzer, MBA, for election to its Supervisory Board. The election will take place at the upcoming General Shareholder Meeting on June 23, 2017. In addition, Dr. Melissa Miller has joined Curetis´ Medical Advisory Board (MAB).